Marker X CO., LTD.
Update：2025/12/24
Industries
Main Industry
Health Care
Main Product/Service
Marker X provides advanced AI proteomics services that combine artificial intelligence with cutting-edge protein analysis technology to promote early disease detection and biomedical innovation. Their core offerings include AI Proteomics Early Cancer Scre
Founded Year
2020
Unified Business No.
82941917
Status
Active
Number of Employees
0
Total Paid-in
Capital
110,814,464 (NT$)
Location of Company
Taiwan
, Taipei City
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, Ministry of Economic Affairs.
Exclusive content for members
Members-only content. Please log in to access.
Introduction
At Marker X, we are dedicated to providing the most accurate and effective multi-cancer early detection (MCED) method. Through the use of cutting-edge proteomic analysis, and artificial intelligence, we are able to detect cancer at its earliest stages, gi
